GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medicover AB (OSTO:MCOV B) » Definitions » EV-to-EBITDA

Medicover AB (OSTO:MCOV B) EV-to-EBITDA : 12.99 (As of May. 28, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Medicover AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medicover AB's enterprise value is kr39,981 Mil. Medicover AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr3,079 Mil. Therefore, Medicover AB's EV-to-EBITDA for today is 12.99.

The historical rank and industry rank for Medicover AB's EV-to-EBITDA or its related term are showing as below:

OSTO:MCOV B' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.48   Med: 13.99   Max: 26.49
Current: 12.98

During the past 10 years, the highest EV-to-EBITDA of Medicover AB was 26.49. The lowest was 9.48. And the median was 13.99.

OSTO:MCOV B's EV-to-EBITDA is ranked worse than
50.54% of 465 companies
in the Healthcare Providers & Services industry
Industry Median: 12.65 vs OSTO:MCOV B: 12.98

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), Medicover AB's stock price is kr190.40. Medicover AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr1.686. Therefore, Medicover AB's PE Ratio for today is 112.93.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Medicover AB EV-to-EBITDA Historical Data

The historical data trend for Medicover AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicover AB EV-to-EBITDA Chart

Medicover AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.17 17.86 21.37 13.06 11.57

Medicover AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.36 13.99 11.76 11.57 10.48

Competitive Comparison of Medicover AB's EV-to-EBITDA

For the Medical Care Facilities subindustry, Medicover AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medicover AB's EV-to-EBITDA falls into.



Medicover AB EV-to-EBITDA Calculation

Medicover AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=39981.057/3078.772
=12.99

Medicover AB's current Enterprise Value is kr39,981 Mil.
Medicover AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3,079 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicover AB  (OSTO:MCOV B) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medicover AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=190.40/1.686
=112.93

Medicover AB's share price for today is kr190.40.
Medicover AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.686.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Medicover AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medicover AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicover AB (OSTO:MCOV B) Business Description

Traded in Other Exchanges
Address
Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, SE-102 46
Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine, and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.

Medicover AB (OSTO:MCOV B) Headlines

No Headlines